In 2016, Jilin Boda Weiye Pharmaceutical Co., Ltd. was successively selected as provincial technology innovation pilot center, provincial technology innovation platform and municipal science and technology innovation center.

Jilin Province Great Cause Pharmaceutical Co., Ltd. is a set of product research and development, production, sales and technology promotion as one of the enterprises. Its main business scope covers the production and sales of chemical drugs, research and development of new drugs, technology transfer and technical consulting services. The company covers an area of 100,000 square meters, assets of 200 million yuan, 235 employees. The company has domestic first-class high-end technical personnel, through independent research and development and foreign cooperation, formed a strong ability of new product research and development. The company has 2800 square meters of multi-functional, modern scientific research room, 30 million yuan worth of advanced instruments and equipment, existing full-time research and development staff of 85 people. It mainly focuses on the research and development of innovative drugs for cardiovascular and cerebrovascular, anti-tumor, digestive system and neuropsychiatric, and focuses on revolutionary drugs in the field of chemical drugs and biological drugs, as well as rapid imitation of products whose international patents are about to expire. Broad weiye pharmaceutical has a good pilot and industrialization base, built with a new version of GMP and eu standards of tablet, capsule, granule, small ShuiZhenJi, transfusion, producing injection production line and chemical intermediates and apis such as comprehensive production workshop, can the pilot production of active pharmaceutical ingredients and the international first-class quality production on a large scale, will provide "jilin chemical pharmaceutical r&d pilot" with good security.